Post-therapy imaging and dosimetry significantly enhance patient management, empowering clinicians to make more informed, ...

AMN Healthcare is undervalued, trading at 3.02x FWD cash flow, with strong demand in therapy and imaging specialties ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

In a UK study, whole-body MRI reveals underrecognised musculoskeletal inflammation in patients on immune checkpoint ...

Far from science fiction, AI is already embedded in hundreds of FDA-cleared tools and is projected to multiply the value of ...

Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.